NEW RICHMOND, WV - Federal health inspectors identified six deficiencies at Wyoming Healthcare Center during a standard health inspection completed on November 19, 2025, including a citation for failing to ensure required monthly pharmaceutical reviews were conducted for residents.
Monthly Drug Reviews Not Conducted as Required
The inspection revealed that Wyoming Healthcare Center did not maintain compliance with federal regulatory tag F0756, which requires skilled nursing facilities to ensure a licensed pharmacist performs a comprehensive drug regimen review for each resident on a monthly basis. The review process must include examination of the resident's medical chart and follow established irregularity reporting guidelines as outlined in the facility's own policies and procedures.
Federal regulations mandate these monthly reviews as a fundamental safeguard for nursing home residents, many of whom take multiple medications simultaneously. The pharmacist review serves as an independent check on prescribing practices, potential drug interactions, and whether each medication remains appropriate for the resident's current condition.
The deficiency was classified at Scope/Severity Level D, indicating an isolated incident where no actual harm was documented but where the potential existed for more than minimal harm to residents. This classification means the problem affected a limited number of residents rather than representing a facility-wide pattern.
Why Pharmacist Reviews Are Critical in Nursing Homes
Nursing home residents are among the most medically vulnerable populations when it comes to medication management. The average long-term care resident takes seven to eight medications daily, and many take considerably more. Each additional medication increases the probability of adverse drug interactions, side effects, and dosing errors.
Monthly drug regimen reviews exist specifically to catch problems that can develop over time. A medication that was appropriate when first prescribed may become problematic as a resident's kidney or liver function changes, as new medications are added, or as the resident's overall health status shifts. Without regular pharmacist oversight, several risks increase:
- Drug interactions between multiple medications may go undetected - Unnecessary medications may continue to be administered after they are no longer needed - Dosage adjustments that should be made based on changing lab values or clinical status may be missed - Side effects that mimic or worsen existing conditions may not be identified as medication-related
When a pharmacist identifies an irregularity during a monthly review, federal regulations require that the finding be reported to the attending physician and the facility's director of nursing. This reporting chain ensures that clinical decision-makers can act promptly to adjust treatment plans.
Six Total Deficiencies Identified
The pharmacy review failure was one of six deficiencies cited during the November 2025 inspection. While the specific details of the remaining five citations were not included in this report, the total number of deficiencies indicates multiple areas where the facility fell short of federal standards during the inspection cycle.
Wyoming Healthcare Center reported a correction date of December 11, 2025, approximately three weeks after the inspection concluded. The facility's status was listed as "deficient, provider has date of correction," meaning the facility acknowledged the problem and committed to a remediation timeline.
Federal Standards for Pharmacy Services
Under the Code of Federal Regulations, every Medicare- and Medicaid-certified nursing facility must provide pharmaceutical services that meet the needs of each resident. This includes maintaining procedures for the monthly drug regimen review, establishing protocols for how irregularities are reported and addressed, and ensuring that the pharmacist conducting the review has access to complete and current medical records.
Facilities that fail to meet these requirements during inspection may face enforcement actions ranging from citations and required corrective action plans to civil monetary penalties for repeated or serious violations.
What Residents and Families Should Know
Families of nursing home residents have the right to ask facility administrators about the status of their loved one's medication reviews. Requesting confirmation that a licensed pharmacist has reviewed the current drug regimen can serve as an additional layer of oversight.
The full inspection report for Wyoming Healthcare Center, including details on all six deficiencies cited during the November 2025 inspection, is available through the Centers for Medicare and Medicaid Services and provides a complete picture of the facility's regulatory compliance status.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Wyoming Healthcare Center from 2025-11-19 including all violations, facility responses, and corrective action plans.
💬 Join the Discussion
Comments are moderated. Please keep discussions respectful and relevant to nursing home care quality.